Altimmune, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Gaithersburg MD United States (1997)

Organization Overview

First Clinical Trial
2008
NCT00755703
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Altimmune, Inc.